To more fully elucidate differences between WT vs. Fgl2−/− tumor-specific CD8+ T cells, OT-I were isolated from the spleens of day-14 B16-OVA challenged mice and sorted for bulk RNA-sequencing followed by downstream analysis of differentially expressed genes through Gene Set Enrichment Analysis (GSEA). This evidence concerns the gene CD8A and neoplasm.